GlassScriptPhysician profile
Stephen C Klepner
NPI 1861871287
$6,647.47
in general payments reported to CMS, 2019-2025
20 companies · $1,534 in 2025
The $1,534 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $454 · 2023: $3,773 · 2024: $887 · 2025: $1,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,502 · Travel and Lodging: $2,291 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,502.22 |
| Travel and Lodging | $2,291.00 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,548.99 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $1,488.49 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $1,215.59 | 2023 | |
| W. L. Gore & Associates, INC. | $723.10 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Mesh Suture INC | $419.29 | 2025 | |
| Dilon Technologies, INC. | $326.39 | 2024 | Hemoblast Bellows |
| Stryker Corporation | $165.04 | 2022 | |
| Boston Scientific Corporation | $154.16 | 2024 | Exalt Model D, Spyglass Discover |
| Baxter Healthcare | $149.99 | 2024 | Tisseel, Floseal |
| Teleflex LLC | $127.25 | 2025 | Titan Sgs Bailout Chuck |
| Davol INC. | $86.62 | 2025 | Phasix Mesh |
| Conmed Corporation | $44.05 | 2025 | Airseal |
| Kerecis Limited | $39.70 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $35.76 | 2025 | |
| Solventum Corporation | $33.17 | 2024 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, V.A.C. Veraflo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $25.41 | 2025 | Restrata Wound Matrix |
| Lsi Solutions INC | $19.12 | 2024 | Cor-Knot |
| Takeda Pharmaceuticals U.S.A., INC. | $17.24 | 2025 | Gattex |
| Smith+Nephew, INC. | $14.74 | 2024 | Pico 7 |
| Ethicon US, LLC | $13.37 | 2023 | Echelon Flex, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Klepner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.